Such alterations are consistent with the hippocampal insulin resistance previously described in Alzheimer’s disease (AD) models, where deficits in receptor and kinase expression impair downstream metabolic and synaptic functions [40,41]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.